Deadline approaching

clock time
Final date close for submissions to controversial drug post-marketing review  Tuesday, 6 June is the last day on which pharmacists can make a submission to a Government review that has called into question the way ezetimibe is prescribed and dispensed to patients with dyslipidemia who are inadequately controlled on, or unable to tolerate, statin therapy.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous 'HIV flourishes in the shadows of stigma.'
Next Sunday pay cuts to start 1 July